Abstract:Background: This study sought to systematically analyze the clinical diagnostic value of tumor markers combined with ThinPrep cytologic test (TCT) and human papillomavirus (HPV) deoxyribonucleic acid (DNA) detection for cervical cancer and pre-cancerous lesions. However, there is a lot of controversy in the field of TCT + HPV-DNA. Many people have mixed opinions on the accuracy of TCT + HPV-DNA, and there is no unified opinion. Therefore, it is necessary to further confirm the significance of this combined detection method in the early diagnosis of cervical cancer by applying meta method. Methods: The Cochrane Library, PubMed, Web of Science, Embase, Chinese Biomedical Literature Database (CBM) databases were searched to retrieve studies. To assess the methodological quality of each study and potential risk of bias, QUADAS-2 Guidelines were used to evaluate the quality of all articles that met the inclusion criteria and data extraction of the included articles were performed, and a meta-analysis was performed of the included studies using Review Manager 5.2 software. Results: A total of 5 studies were included in the study, and a total of 2,778 patients were included in the study, and there was no significant publication bias observed. The meta-analysis showed that there was a statistical difference in terms of the accuracy of the tumor markers combined with TCT in the detection of cervical cancer. The results were as follows: the pooled sensitivity (SEN) was 0.86 (95% CI: 0.75-0.93); the combined specificity (SPE) was 0.79 (95% CI: 0.57-0.92); the diagnostic performance of combined with thin-layer liquid-based cytology and HPV DNA detection in the diagnosis accuracy of cervical cancer by summary receiver operating characteristic (SROC) curve analysis, result showed excellent diagnostic accuracy, with a combined area under the curve (AUC) of 0.90 (95% CI: 0.87-0.92). Discussion: Tumor markers are important for the early diagnosis of cervical cancer. Combining the tumor markers with TCT and HPV DNA detection effectively improved the detection rate.

Thinprep cytologic test results of 15 000 cases and diagnosis analysis

Clinical Analysis of Ziquid-Based Cytology in 2198 Cases of Cervical Cancer Screening

Clinical Analysis on Detection of 10 539 Cases with Thinprep Cytology Test

Clinical Analysis of 72 Cases of Cervical Intraepithelial Neoplsia

Relativity Analysis of Thin-Prep-liquid-based cytology test and pathologic histology for diagnosis of cervical lesion

A Study of Thinprep Cytologic Test Combined with Human Papilloma Virus Hybrid CaptureⅡ DNA Test and Biopsy-Control in Cervical Lesions

Artificial Classification of Cervical Squamous Lesions in ThinPrep Cytologic Tests Using a Deep Convolutional Neural Network.

Clinical analysis on results of cervical cytology screening:report of 6498 cases

The diagnostic accuracy of TCT plus HPV-DNA for cervical cancer: systematic review and meta-analysis

Clinical analysis of 301 patients with CIN3

Significance of TCT combined HPV testing in screening of uterine cervix cancer

Analysis of Diagnosis and Follow-Up Results in 135 CIN Patients

Application research of TCT DNA quantification combined with Ki67 P16 immunohistochemistry in screening cervical cancer and precancerous diseases

Application of Liquid Based Cytology and High-risk Human Papillomavirus DNA Test for the Screening Cervical Lesions

Value of Cervical Cytologic Tests and Colposcopy in Diagnosis of Cervical Lesions

A histological analysis of atypical squamous cells of undetermined significance in cervix

Study on Cervix Carcinoma Screening with Liquid-based Cytology Test

Application of Hterc in Thinprep Samples with Mild Cytologic Abnormality and HR-HPV Positive

Meaning of fluid based thin-layer cytological test system united with cervical biopsy under colposcope in diagnosing pathological changes of cervix uteri

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Study on Liquid -Based Cytoloty for Cervical Carcinoma Screening